# Facility Definition Under Section 503B of the Federal Food, Drug, and Cosmetic Act - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/facility-definition-under-section-503b-of-the-federal-food-drug-and-cosmetic-act/0757072b-35f4-40f5-97ac-c401faa17cb3

> FDA guidance document: Facility Definition Under Section 503B of the Federal Food, Drug, and Cosmetic Act. Issue date: May 10, 2018. Get complete insights and analysis.

---

## Details

- Title: Facility Definition Under Section 503B of the Federal Food, Drug, and Cosmetic Act
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-05-10
- Last Changed: 2019-04-01

## Related Documents

- [Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act](https://www.globalkeysolutions.net/guidances/guidance-document/evaluation-of-bulk-drug-substances-nominated-for-use-in-compounding-under-section-503b-of-the-federal-food-drug-and-cosmetic-act/32f6b565-3151-4e63-8311-63f0e604bece)
- [Prescription Requirement Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/prescription-requirement-under-section-503a-of-the-federal-food-drug-and-cosmetic-act-guidance-for-industry/2deca755-c1a3-4959-81be-63a489f8e69c)
- [Adverse Event Reporting for Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act](https://www.globalkeysolutions.net/guidances/guidance-document/adverse-event-reporting-for-outsourcing-facilities-under-section-503b-of-the-federal-food-drug-and-cosmetic-act/4c23f98f-eaf3-4ed1-8f57-33ea6ba03529)